
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)
PDB | Ligand | Drug | Indication | Macromolecule/ Organism |
Pfam | Binding_Interfaces (View) | Details |
---|---|---|---|---|---|---|---|
4qc6 | KAN | Kanamycin (DB01172) | Kanamycin is an aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria. | BIFUNCTIONAL AAC/APH (Staphylococcus warneri) | Acetyltransf_8 | ||
5iqb | KAN | Kanamycin (DB01172) | Kanamycin is an aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria. | BIFUNCTIONAL AAC/APH (Staphylococcus aureus) | APH | ||
5iqd | RIO | Ribostamycin (DB03615) | Ribostamycin is a broad spectrum aminoglycoside antibiotic on the list of WHO critical antimicrobials for human medicine. | BIFUNCTIONAL AAC/APH (Staphylococcus aureus) | APH | ||
5iqe | NMY | Framycetin (DB00452) | Framycetin is an aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus. | BIFUNCTIONAL AAC/APH (Staphylococcus aureus) | APH | ||
6cav | 84D | Dibekacin (DB13270) | Dibekacin is an aminoglycoside antibiotic marketed in Japan . | BIFUNCTIONAL AAC/APH (Staphylococcus aureus) | APH | ||
6cgd | AKN | Amikacin (DB00479) | Amikacin is an aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria. | BIFUNCTIONAL AAC/APH (Staphylococcus aureus) | APH | ||
PDB | Ligand | Drug | Indication | Macromolecule/ Organism |
Pfam | Binding_Interfaces (View) | Details |